Israel Medica2010 Companies Catalogue - Israeli-South African ...

3QBD
Back to TOC
www.3qbd.com
Company at a Glance
Located in Arad, Israel, 3QBD Ltd. is an ISO certified startup medical device company. The company has
developed the VGTest, a gynecological diagnostic device based on Ion Mobility Spectrometry (IMS) which is
used in the detection of vaginal infections.
In December 2009, 3QBD Ltd. received the European CE mark for the VGTest, a device capable of detecting
and returning a positive/negative result for Bacterial Vaginosis, the most prevalent women’s vaginal
infection, within 60 seconds.
Future development plans for 3QBD include expanding research further into the medical field, to detect
additional major infections and diseases and offer rapid, accurate results. Other applications for the
technology include cancer, food and livestock.
Category, Subcategory & Therapeutic Area(s)
Category:
Subcategory:
Therapeutic Area(s):
Company Status:
Medical Devices
Diagnostics
Gynecology, Obstetrics, Women's Health
Clinical Trials, Regulatory Approval
Technology & Product(s)
IMS (Ion Mobility Spectrometry) Technology
3QBD's technology is based on the well-established and scientifically proven Ion Mobility Spectrometry
(IMS) technology – first used successfully to detect drugs and explosives. Today IMS is being used to detect
presence and type of infection.
Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial
processes, are accompanied by the breakdown of amino acids and production of biogenic amines.
Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that
elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental
technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility)
drifting through a gas bath under the influence of an electric field.
The Product
The device works by measuring biogenic amines that are present at elevated levels in infections and
diseases, and returns a rapid accurate result. In the case of Bacterial Vaginosis the result is provided within
one minute. In addition, the VGTest for BV spares the physician from having to perform the Amsel Test and
“whiff tests” of vaginal fluid, or spend time waiting for laboratory Gram Stain results.
Goal
Objectives:
Target Businesses:
Target Countries:
Distribution, R&D Funding
Women’s health professionals, gynecologists, obstetricians, hospitals and health
clinics
Worldwide
8